Morag Griffin
Leeds Teaching Hospitals NHS Trust(GB)St James's University Hospital(GB)
Publications by Year
Research Areas
Complement system in diseases, Blood groups and transfusion, Renal Diseases and Glomerulopathies, Coagulation, Bradykinin, Polyphosphates, and Angioedema, Hemoglobinopathies and Related Disorders
Most-Cited Works
- → Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria(2021)365 cited
- → Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia(2022)277 cited
- → Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria(2024)128 cited
- → Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline(2024)98 cited
- → Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trial(2023)81 cited
- → Pegcetacoplan versus eculizumab in patients with paroxysmal nocturnal haemoglobinuria (PEGASUS): 48-week follow-up of a randomised, open-label, phase 3, active-comparator, controlled trial(2022)67 cited
- → Long‐term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2‐year results from two pivotal phase 3 studies(2022)60 cited
- → Management of thrombosis in paroxysmal nocturnal hemoglobinuria: a clinician’s guide(2016)60 cited
- → The incidence and prevalence of patients with paroxysmal nocturnal haemoglobinuria and aplastic anaemia PNH syndrome: A retrospective analysis of the UK’s population‐based haematological malignancy research network 2004‐2018(2021)58 cited
- → Treatment outcomes of complement protein C5 inhibition in 509 UK patients with paroxysmal nocturnal hemoglobinuria(2023)45 cited